Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

An update of safety of clinically used atypical antipsychotics

Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., Martinotti, G., Mazza, M., Perna, G., Carano, A., De Bartolomeis, A., Di Giannantonio, M., De Berardis, D. · 2016 · Expert Opinion on Drug Safety

Abstract

INTRODUCTION: The atypical antipsychotic (APs) drugs have become the most widely used agents to treat a variety of psychoses because of their superiority with regard to safety and tolerability profile compared to conventional/'typical' APs. AREAS COVERED: We aimed at providing a synthesis of most current evidence about the safety and tolerability profile of the most clinically used atypical APs so far marketed. Qualitative synthesis followed an electronic search made inquiring of the following databases: MEDLINE, Embase, PsycINFO and the Cochrane Library from inception until January 2016, combining free terms and MESH headings for the topics of psychiatric disorders and all atypical APs as following: ((safety OR adverse events OR side effects) AND (aripiprazole OR asenapine OR quetiapine OR olanzapine OR risperidone OR paliperidone OR ziprasidone OR lurasidone OR clozapine OR amisulpride OR iloperidone)). EXPERT OPINION: A critical issue in the treatment with atypical APs is represented by their metabolic side effect profile (e.g. weight gain, lipid and glycaemic imbalance, risk of diabetes mellitus and diabetic ketoacidosis) which may limit their use in particular clinical samples. Electrolyte imbalance, ECG abnormalities and cardiovascular adverse effects may recommend a careful baseline and periodic assessments.

Overview

Integrity signals

Registry

Crossref · 10.1080/14740338.2016.1201475

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

The citation lists are queued

They are fetched later and appear here then.

References 167 · Cited by 135

Research works printed but not linked: 22

  1. Laricchia R, 1956, Encephale, 45, 1197
  2. WHO, 1992, International monitoring of adverse reactions to drugs: adverse reaction terminology
  3. Muench J, 2010, American Family Physician, 81, 617
  4. Bleakley S, 2013, The clozapine handbook
  5. Prakash C, 1997, Drug Metab Dispos, 25, 206
  6. Ozdemir V, 2002, Curr Opin Investig Drugs, 3, 113
  7. Physician Assistants Prescribing R, 2010, JAAPA, 23, 16
  8. 10.1177/0269881107082944 · DOI · Paper page
  9. Bishara D, 2009, Neuropsychiatr Dis Treat, 5, 483
  10. Meltzer HY, 1994, J Clin Psychiatry, 55, 47
  11. 10.1517/14740338.2015.974549 · DOI · Paper page
  12. Chandrasekaran PK, 2008, Singapore Med J, 49, 96
  13. Demler TL, 2011, Innov Clin Neurosci, 8, 35
  14. Woo YS, 2013, Neuropsychiatr Dis Treat, 9, 1521
  15. Bymaster FP, 1997, J Clin Psychiatry, 58, 28
  16. Zhao Z, 2015, Int J Clin Exp Med, 8, 11639
  17. Gonzalez-Rodriguez A, 2015, Patient Prefer Adherence, 9, 695
  18. Leysen JE, 1994, J Clin Psychiatry, 55, 12
  19. Kelly DL, 2001, Psychopharmacol Bull, 35, 66
  20. Gordon JS, 2012, Cutis, 89, 180
  21. Li C-H, 2013, Eur Rev Med Pharmacol Sci, 17, 2136
  22. Campbell N, 2009, Clin Interv Aging, 4, 225

Metadata

Authors
Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., Martinotti, G., Mazza, M., Perna, G., Carano, A., De Bartolomeis, A., Di Giannantonio, M., & De Berardis, D.
Affiliations
  • University of Hertfordshire (GB)
  • University of Naples Federico II (IT)
  • Hermanas Hospitalarias del Sagrado Corazón de Jesús (IT)
  • Maastricht University (NL)
  • University of Chieti-Pescara (IT)
  • Columbia University (US)
  • Polyedra Research Group, Teramo, Italy
  • University of L'Aquila (IT)
  • University of Miami (US)
  • NHS, Department of Mental Health ASL Ascoli Piceno, Psychiatric Service of Diagnosis and Treatment, Hospital ‘Maria SS del Soccorso,’ San Benedetto del Tronto, Italy
  • Laboratory of Molecular and Translational Psychiatry, Department of Neuroscience, Reproductive and Odontostomatogical Sciences, University of Naples ‘Federico II,’ Napoli, Italy
  • New York Psychiatric Institute, Columbia University, New York, NY, USA
Venue
Expert Opinion on Drug Safety
Published
2016-07-04
Volume
15
Issue
10
Pages
1329-1347
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W2474134945
Cited by
135
References
167
Citations by year
2026: 5 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 15 · 2021: 12 · 2020: 16 · 2019: 28 · 2018: 18 · 2017: 10 · 2016: 5
FWCI
2.90
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
atypical antipsychotics, drug safety, tolerability, adverse drug reactions, metabolic side effects, weight gain, diabetes mellitus, diabetic ketoacidosis, electrolyte imbalance, electrocardiographic abnormalities, cardiovascular adverse events, psychosis, aripiprazole, asenapine, quetiapine, olanzapine, risperidone, paliperidone, ziprasidone, lurasidone, clozapine, amisulpride, iloperidone
MeSH terms
Cardiovascular Diseases, Electrocardiography, Humans, Metabolic Diseases, Antipsychotic Agents, Water-Electrolyte Balance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An update of safety of clinically used atypical antipsychotics. https://app.cochat.ai/papers/10.1080/14740338.2016.1201475
The paper
Orsolini, L., Tomasetti, C., Valchera, A., Vecchiotti, R., Matarazzo, I., Vellante, F., Iasevoli, F., Buonaguro, E. F., Fornaro, M., Fiengo, A. L. C., Martinotti, G., Mazza, M., Perna, G., Carano, A., De Bartolomeis, A., Di Giannantonio, M., & De Berardis, D. (2016). An update of safety of clinically used atypical antipsychotics. Expert Opinion on Drug Safety. https://doi.org/10.1080/14740338.2016.1201475

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.